Naperville, IL -- (SBWire) -- 12/19/2012 --LABORATOIRES THEA - Product Pipeline Review - 2012 provides data on the LABORATOIRES THEA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- LABORATOIRES THEA - Brief LABORATOIRES THEA overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of LABORATOIRES THEA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of LABORATOIRES THEA with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the LABORATOIRES THEA’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate LABORATOIRES THEA’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of LABORATOIRES THEA in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the LABORATOIRES THEA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with LABORATOIRES THEA.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of LABORATOIRES THEA and identify potential opportunities in those areas.

To view table of contents for this market report please visit:
http://www.reportstack.com/product/91557/laboratoires-thea-product-pipeline-review-2012.html